Swiss Life Asset Management Ltd Grows Position in GE HealthCare Technologies Inc. $GEHC

Swiss Life Asset Management Ltd boosted its position in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 111.1% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 170,883 shares of the company’s stock after purchasing an additional 89,951 shares during the period. Swiss Life Asset Management Ltd’s holdings in GE HealthCare Technologies were worth $12,833,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. True North Advisors LLC lifted its stake in GE HealthCare Technologies by 2.0% in the third quarter. True North Advisors LLC now owns 6,987 shares of the company’s stock worth $525,000 after purchasing an additional 139 shares during the last quarter. Klingman & Associates LLC grew its stake in shares of GE HealthCare Technologies by 4.0% during the third quarter. Klingman & Associates LLC now owns 3,634 shares of the company’s stock valued at $273,000 after buying an additional 139 shares during the last quarter. Colonial Trust Advisors raised its holdings in shares of GE HealthCare Technologies by 11.1% in the third quarter. Colonial Trust Advisors now owns 1,391 shares of the company’s stock worth $104,000 after buying an additional 139 shares during the period. Norinchukin Bank The raised its holdings in shares of GE HealthCare Technologies by 0.4% in the third quarter. Norinchukin Bank The now owns 38,913 shares of the company’s stock worth $2,922,000 after buying an additional 149 shares during the period. Finally, Exchange Traded Concepts LLC lifted its stake in shares of GE HealthCare Technologies by 1.3% during the 3rd quarter. Exchange Traded Concepts LLC now owns 11,490 shares of the company’s stock worth $863,000 after acquiring an additional 150 shares during the last quarter. 82.06% of the stock is owned by hedge funds and other institutional investors.

GE HealthCare Technologies Trading Down 1.1%

Shares of NASDAQ GEHC opened at $69.61 on Friday. The company has a quick ratio of 1.13, a current ratio of 1.37 and a debt-to-equity ratio of 0.91. The business has a fifty day simple moving average of $79.22 and a two-hundred day simple moving average of $78.38. The firm has a market cap of $31.72 billion, a PE ratio of 15.26, a price-to-earnings-growth ratio of 1.55 and a beta of 1.03. GE HealthCare Technologies Inc. has a twelve month low of $57.65 and a twelve month high of $89.77.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Wednesday, February 4th. The company reported $1.44 EPS for the quarter, beating the consensus estimate of $1.40 by $0.04. The firm had revenue of $5.70 billion for the quarter, compared to analyst estimates of $5.60 billion. GE HealthCare Technologies had a return on equity of 21.35% and a net margin of 10.11%.The business’s revenue for the quarter was up 7.1% on a year-over-year basis. During the same quarter last year, the firm posted $1.45 earnings per share. GE HealthCare Technologies has set its FY 2026 guidance at 4.950-5.150 EPS. Analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, May 15th. Shareholders of record on Friday, April 3rd will be given a dividend of $0.035 per share. The ex-dividend date of this dividend is Thursday, April 2nd. This represents a $0.14 dividend on an annualized basis and a yield of 0.2%. GE HealthCare Technologies’s dividend payout ratio (DPR) is 3.07%.

Wall Street Analyst Weigh In

A number of equities analysts recently issued reports on GEHC shares. Citigroup dropped their price objective on GE HealthCare Technologies from $88.00 to $84.00 and set a “neutral” rating for the company in a report on Wednesday, March 11th. UBS Group downgraded GE HealthCare Technologies from a “neutral” rating to a “sell” rating and lifted their target price for the stock from $73.00 to $77.00 in a research report on Thursday, January 15th. BTIG Research reissued a “buy” rating and set a $91.00 target price on shares of GE HealthCare Technologies in a research note on Thursday. The Goldman Sachs Group restated a “buy” rating and issued a $98.00 price target on shares of GE HealthCare Technologies in a report on Friday, January 9th. Finally, Piper Sandler raised their price target on shares of GE HealthCare Technologies from $91.00 to $94.00 and gave the stock an “overweight” rating in a research note on Friday, January 30th. Seven investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the company’s stock. Based on data from MarketBeat, GE HealthCare Technologies currently has a consensus rating of “Hold” and an average price target of $92.17.

GE HealthCare Technologies Profile

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime.